Fig. 1From: Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysisFlowchart of study selection process. Abbreviations: OS, overall survival; PFS, progression-free survival; NSCLC, non-small cell lung cancer; RCC, renal cell carcinomaBack to article page